{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:43:04Z","timestamp":1771231384419,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7172212"],"award-info":[{"award-number":["7172212"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Hospitals Authority Innovation Studio of Young Staff Funding","award":["202136"],"award-info":[{"award-number":["202136"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Microbiol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12088-024-01278-7","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T07:01:56Z","timestamp":1716793316000},"page":"1929-1937","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enhanced Immune Responses Against Mycobacterium tuberculosis Through Heat-Killed BCG with Squalene-in-water Emulsion Adjuvant"],"prefix":"10.1007","volume":"64","author":[{"given":"Chuanzhi","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingde","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuyun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"1278_CR1","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/resp.12120","volume":"18","author":"SS Lee","year":"2013","unstructured":"Lee SS, Meintjes G, Kamarulzaman A, Leung CC (2013) Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons. Respirology 18:912\u2013922. https:\/\/doi.org\/10.1111\/resp.12120","journal-title":"Respirology"},{"key":"1278_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.intimp.2017.10.026","volume":"54","author":"Q Li","year":"2018","unstructured":"Li Q, Zhang H, Yu L et al (2018) Down-regulation of Notch signaling pathway reverses the Th1\/Th2 imbalance in tuberculosis patients. Int Immunopharmacol 54:24\u201332. https:\/\/doi.org\/10.1016\/j.intimp.2017.10.026","journal-title":"Int Immunopharmacol"},{"key":"1278_CR3","doi-asserted-by":"publisher","unstructured":"Dobbs TE, Webb RM (2017) Chemotherapy of tuberculosis. Tuberc Nontuberculous Mycobact Infect 101\u2013117. https:\/\/doi.org\/10.1128\/9781555819866.ch7","DOI":"10.1128\/9781555819866.ch7"},{"key":"1278_CR4","doi-asserted-by":"publisher","first-page":"114588","DOI":"10.1016\/j.biopha.2023.114588","volume":"162","author":"S Ayodele","year":"2023","unstructured":"Ayodele S, Kumar P, van Eyk A, Choonara YE (2023) Advances in immunomodulatory strategies for host-directed therapies in combating tuberculosis. Biomed Pharmacother 162:114588. https:\/\/doi.org\/10.1016\/j.biopha.2023.114588","journal-title":"Biomed Pharmacother"},{"key":"1278_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2021.763591","volume":"11","author":"J Mi","year":"2021","unstructured":"Mi J, Liang Y, Liang J et al (2021) The research progress in immunotherapy of tuberculosis. Front Cell Infect Microbiol 11:1\u201317. https:\/\/doi.org\/10.3389\/fcimb.2021.763591","journal-title":"Front Cell Infect Microbiol"},{"key":"1278_CR6","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","volume":"109","author":"J Kleinnijenhuis","year":"2012","unstructured":"Kleinnijenhuis J, Quintin J, Preijers F et al (2012) Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA 109:17537\u201317542. https:\/\/doi.org\/10.1073\/pnas.1202870109","journal-title":"Proc Natl Acad Sci USA"},{"key":"1278_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000355628","volume":"6","author":"J Kleinnijenhuis","year":"2014","unstructured":"Kleinnijenhuis J, Quintin J, Preijers F et al (2014) Long-lasting effects of bcg vaccination on both heterologous Th1\/Th17 responses and innate trained immunity. J Innate Immun 6:152\u2013158. https:\/\/doi.org\/10.1159\/000355628","journal-title":"J Innate Immun"},{"key":"1278_CR8","doi-asserted-by":"publisher","first-page":"109208","DOI":"10.1016\/j.clim.2022.109208","volume":"246","author":"PA Debisarun","year":"2023","unstructured":"Debisarun PA, Kilic G, de Bree LCJ et al (2023) The impact of BCG dose and revaccination on trained immunity. Clin Immunol 246:109208. https:\/\/doi.org\/10.1016\/j.clim.2022.109208","journal-title":"Clin Immunol"},{"key":"1278_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-017-0271-0","volume":"5","author":"AM Kamat","year":"2017","unstructured":"Kamat AM, Bellmunt J, Galsky MD et al (2017) Society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of bladder carcinoma. J Immunother Cancer 5:1\u201316. https:\/\/doi.org\/10.1186\/s40425-017-0271-0","journal-title":"J Immunother Cancer"},{"key":"1278_CR10","doi-asserted-by":"publisher","first-page":"12596","DOI":"10.3390\/ijms241612596","volume":"24","author":"F Claps","year":"2023","unstructured":"Claps F, Pavan N, Ongaro L et al (2023) BCG-unresponsive non-muscle-invasive bladder cancer: Current treatment landscape and novel emerging molecular targets. Int J Mol Sci 24:12596. https:\/\/doi.org\/10.3390\/ijms241612596","journal-title":"Int J Mol Sci"},{"key":"1278_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2022-005518","volume":"11","author":"JH Van Puffelen","year":"2023","unstructured":"Van Puffelen JH, Novakovic B, Van Emst L et al (2023) Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections. J Immunother Cancer 11:1\u201320. https:\/\/doi.org\/10.1136\/jitc-2022-005518","journal-title":"J Immunother Cancer"},{"key":"1278_CR12","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1021\/acs.molpharmaceut.8b00919","volume":"15","author":"H Masuda","year":"2018","unstructured":"Masuda H, Nakamura T, Noma Y, Harashima H (2018) Application of BCG-CWS as a systemic adjuvant by using nanoparticulation technology. Mol Pharm 15:5762\u20135771. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00919","journal-title":"Mol Pharm"},{"key":"1278_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.557809","volume":"11","author":"S Afkhami","year":"2020","unstructured":"Afkhami S, Villela AD, D\u2019Agostino MR et al (2020) Advancing immunotherapeutic vaccine strategies against pulmonary tuberculosis. Front Immunol 11:1\u201310. https:\/\/doi.org\/10.3389\/fimmu.2020.557809","journal-title":"Front Immunol"},{"key":"1278_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00430-012-0278-6","volume":"202","author":"SA Prabowo","year":"2013","unstructured":"Prabowo SA, Gr\u00f6schel MI, Schmidt EDL et al (2013) Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines. Med Microbiol Immunol 202:95\u2013104. https:\/\/doi.org\/10.1007\/s00430-012-0278-6","journal-title":"Med Microbiol Immunol"},{"key":"1278_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.juro.2013.09.012","volume":"191","author":"G Shah","year":"2014","unstructured":"Shah G, Zhang G, Chen F et al (2014) Loss of bacillus Calmette\u2013Gu\u00e9rin viability adversely affects the direct response of urothelial carcinoma cells to bacillus Calmette\u2013Gu\u00e9rin exposure. J Urol 191:823\u2013829. https:\/\/doi.org\/10.1016\/j.juro.2013.09.012","journal-title":"J Urol"},{"key":"1278_CR16","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.vaccine.2003.10.016","volume":"22","author":"M Haile","year":"2004","unstructured":"Haile M, Schr\u00f6der U, Hamasur B et al (2004) Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine\u2122 L3 adjuvant protects against tuberculosis. Vaccine 22:1498\u20131508. https:\/\/doi.org\/10.1016\/j.vaccine.2003.10.016","journal-title":"Vaccine"},{"key":"1278_CR17","first-page":"47","volume":"12","author":"E Studies","year":"1955","unstructured":"Studies E, Vaccination OF (1955) Experimental studies of vaccination, allergy, and immunity in tuberculosis: 3. Effect of killed BCG vaccine. Bull World Health Organ 12:47\u201362","journal-title":"Bull World Health Organ"},{"key":"1278_CR18","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/j.1365-2133.2011.10763.x","volume":"166","author":"M Kakeda","year":"2012","unstructured":"Kakeda M, Yamanaka K, Kitagawa H et al (2012) Heat-killed bacillus Calmette\u2013Gu\u00e9rin and Mycobacterium kansasii antigen 85B combined vaccination ameliorates dermatitis in a mouse model of atopic dermatitis by inducing regulatory T cells. Br J Dermatol 166:953\u2013963. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10763.x","journal-title":"Br J Dermatol"},{"key":"1278_CR19","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1080\/21645515.2017.1335374","volume":"13","author":"CY Huang","year":"2017","unstructured":"Huang CY, Hsieh WY (2017) Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis. Hum Vaccines Immunother 13:1960\u20131971. https:\/\/doi.org\/10.1080\/21645515.2017.1335374","journal-title":"Hum Vaccines Immunother"},{"key":"1278_CR20","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.rmed.2005.09.026","volume":"100","author":"D Dlugovitzky","year":"2006","unstructured":"Dlugovitzky D, Fiorenza G, Farroni M et al (2006) Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis. Respir Med 100:1079\u20131087. https:\/\/doi.org\/10.1016\/j.rmed.2005.09.026","journal-title":"Respir Med"},{"key":"1278_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2217\/imt.11.6","volume":"3","author":"D Dlugovitzky","year":"2011","unstructured":"Dlugovitzky D, Stanford C, Stanford J (2011) Immunological basis for the introduction of immunotherapy with Mycobacterium vaccae into the routine treatment of TB. Immunotherapy 3:557\u2013568. https:\/\/doi.org\/10.2217\/imt.11.6","journal-title":"Immunotherapy"},{"key":"1278_CR22","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1080\/21645515.2018.1495301","volume":"14","author":"E Ko","year":"2018","unstructured":"Ko E, Kang S (2018) Immunology and efficacy of MF59-adjuvanted vaccines. Hum Vaccin Immunother 14:3041\u20133045. https:\/\/doi.org\/10.1080\/21645515.2018.1495301","journal-title":"Hum Vaccin Immunother"},{"key":"1278_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2023.2190279","volume":"19","author":"D Amicizia","year":"2023","unstructured":"Amicizia D, Domnich A, Luigi P et al (2023) Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021\/2022 influenza season ABSTRACT. Hum Vaccin Immunother 19:1\u20135. https:\/\/doi.org\/10.1080\/21645515.2023.2190279","journal-title":"Hum Vaccin Immunother"},{"key":"1278_CR24","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.vaccine.2005.09.046","volume":"24","author":"M Singh","year":"2006","unstructured":"Singh M, Ugozzoli M, Kazzaz J et al (2006) A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens. Vaccine 24:1680\u20131686. https:\/\/doi.org\/10.1016\/j.vaccine.2005.09.046","journal-title":"Vaccine"},{"key":"1278_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0122560","volume":"10","author":"X Wang","year":"2015","unstructured":"Wang X, Zhang J, Liang J et al (2015) Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-\u03b3+IL-2+ CD4+and IFN-\u03b3+ CD8+ T cells. PLoS ONE 10:1\u201318. https:\/\/doi.org\/10.1371\/journal.pone.0122560","journal-title":"PLoS ONE"},{"key":"1278_CR26","first-page":"651","volume":"08","author":"S Qingde","year":"2015","unstructured":"Qingde S, Xiangyu H, Chuanzhi Z, Junli L, Li X, Yu G, Xihui M, Xiangrui K, Xiuyun H (2015) MF59\/hBCG combination adjuvant enhances the recruitment and MCP-1 secretion of macrophages. Immunol J 08:651\u2013657","journal-title":"Immunol J"},{"key":"1278_CR27","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1038\/ncomms7059","volume":"6","author":"P Tiwari","year":"2015","unstructured":"Tiwari P, Arora G, Singh M et al (2015) MazF ribonucleases promote Mycobacterium tuberculosis drug tolerance and virulence in guinea pigs. Nat Commun 6:6059. https:\/\/doi.org\/10.1038\/ncomms7059","journal-title":"Nat Commun"},{"key":"1278_CR28","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1016\/j.vaccine.2019.06.078","volume":"37","author":"C Wang","year":"2019","unstructured":"Wang C, Lu J, Du W et al (2019) Ag85b\/ESAT6-CFP10 adjuvanted with aluminum\/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection. Vaccine 37:4477\u20134484. https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.078","journal-title":"Vaccine"},{"key":"1278_CR29","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S1286-4579(03)00179-5","volume":"5","author":"XY He","year":"2003","unstructured":"He XY, Zhuang YH, Zhang XG, Li GL (2003) Comparative proteome analysis of culture supernatant proteins of Mycobacterium tuberculosis H37Rv and H37Ra. Microbes Infect 5:851\u2013856. https:\/\/doi.org\/10.1016\/S1286-4579(03)00179-5","journal-title":"Microbes Infect"},{"key":"1278_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1083\/jcb.202102055","volume":"221","author":"D Camargo","year":"2022","unstructured":"Camargo D, Simoes M, Paschalidis N et al (2022) An integrin axis induces IFN- \u03b2 production in plasmacytoid dendritic cells. J Cell Biol 221:1\u201316. https:\/\/doi.org\/10.1083\/jcb.202102055","journal-title":"J Cell Biol"},{"key":"1278_CR31","doi-asserted-by":"publisher","first-page":"308","DOI":"10.5582\/bst.2017.01104","volume":"11","author":"T Zhang","year":"2017","unstructured":"Zhang T, Zhu Q, Shao Y et al (2017) Paeoniflorin prevents TLR2\/4-mediated inflammation in type 2 diabetic nephropathy. Biosci Trends 11:308\u2013318. https:\/\/doi.org\/10.5582\/bst.2017.01104","journal-title":"Biosci Trends"},{"key":"1278_CR32","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41419-018-0532-y","volume":"9","author":"Y Gu","year":"2018","unstructured":"Gu Y, Ding X, Huang J et al (2018) The deubiquitinating enzyme UCHL1 negatively regulates the immunosuppressive capacity and survival of multipotent mesenchymal stromal cells. Cell Death Dis 9:459. https:\/\/doi.org\/10.1038\/s41419-018-0532-y","journal-title":"Cell Death Dis"},{"key":"1278_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.876579","volume":"13","author":"Y Liang","year":"2022","unstructured":"Liang Y, Cui L, Xiao L et al (2022) Immunotherapeutic effects of different doses of Mycobacterium tuberculosis ag85a\/b DNA vaccine delivered by electroporation. Front Immunol 13:1\u201310. https:\/\/doi.org\/10.3389\/fimmu.2022.876579","journal-title":"Front Immunol"},{"key":"1278_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-020-0187-4","volume":"5","author":"J de Jonge","year":"2020","unstructured":"de Jonge J, van Dijken H, de Heij F et al (2020) H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets. npj Vaccines 5:1\u201314. https:\/\/doi.org\/10.1038\/s41541-020-0187-4","journal-title":"npj Vaccines"},{"key":"1278_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a018572","volume":"5","author":"S Clark","year":"2015","unstructured":"Clark S, Hall Y, Williams A (2015) Animal models of tuberculosis: Guinea pigs. Cold Spring Harb Perspect Med 5:1\u201310. https:\/\/doi.org\/10.1101\/cshperspect.a018572","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1278_CR36","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","volume":"168","author":"DR Roach","year":"2002","unstructured":"Roach DR, Bean AGD, Demangel C et al (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma Formation, and clearance of mycobacterial infection. J Immunol 168:4620\u20134627. https:\/\/doi.org\/10.4049\/jimmunol.168.9.4620","journal-title":"J Immunol"},{"key":"1278_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0194430","volume":"13","author":"DA Alves da Silva","year":"2018","unstructured":"Alves da Silva DA, Da Silva MV, Oliveira Barros CC et al (2018) TNF-\u03b1 blockade impairs in vitro tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines. PLoS ONE 13:1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0194430","journal-title":"PLoS ONE"},{"key":"1278_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-6-14","volume":"6","author":"Z Hasan","year":"2005","unstructured":"Hasan Z, Zaidi I, Jamil B et al (2005) Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis. BMC Immunol 6:1\u201310. https:\/\/doi.org\/10.1186\/1471-2172-6-14","journal-title":"BMC Immunol"},{"key":"1278_CR39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","volume":"2","author":"BR Bloom","year":"1995","unstructured":"Bloom BR, Triebold KJ, Flynn JL et al (1995) Tumor necrosis factor-\u03b1 is required in the protective immune response against mycobacterium tuberculosis in mice. Immunity 2:561\u2013572. https:\/\/doi.org\/10.1016\/1074-7613(95)90001-2","journal-title":"Immunity"},{"key":"1278_CR40","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.cell.2019.08.004","volume":"178","author":"FJ Roca","year":"2019","unstructured":"Roca FJ, Whitworth LJ, Redmond S et al (2019) TNF induces pathogenic programmed macrophage necrosis in tuberculosis through a mitochondrial-lysosomal-endoplasmic reticulum circuit. Cell 178:1344\u20131361. https:\/\/doi.org\/10.1016\/j.cell.2019.08.004","journal-title":"Cell"},{"key":"1278_CR41","doi-asserted-by":"publisher","unstructured":"Dub\u00e9a CM, Brewstera AL, TZB, Badr H, Carmack CL, Kashy DA, Cristofanilli M, TAR (2012) The tumor necrosis family member 4-1BBL sustains inflammation by interacting with mediators of toll-like receptor signalling. Bone 23:1\u20137. https:\/\/doi.org\/10.1126\/scisignal.2004431","DOI":"10.1126\/scisignal.2004431"},{"key":"1278_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2017.00314","volume":"7","author":"S Park","year":"2017","unstructured":"Park S, Baek S-H, Cho S-N et al (2017) Unique chemokine profiles of lung tissues distinguish post-chemotherapeutic persistent and chronic tuberculosis in a mouse model. Front Cell Infect Microbiol 7:1\u201310. https:\/\/doi.org\/10.3389\/fcimb.2017.00314","journal-title":"Front Cell Infect Microbiol"},{"key":"1278_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/405310","volume":"2011","author":"R Van Crevel","year":"2011","unstructured":"Van Crevel R, Kleinnijenhuis J, Oosting M et al (2011) Innate immune recognition of mycobacterium tuberculosis. Clin Dev Immunol 2011:1\u201312. https:\/\/doi.org\/10.1155\/2011\/405310","journal-title":"Clin Dev Immunol"},{"key":"1278_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2012.00145","volume":"2","author":"J Basu","year":"2012","unstructured":"Basu J, Shin DM, Jo EK (2012) Mycobacterial signaling through toll-like receptors. Front Cell Infect Microbiol 2:1\u20136. https:\/\/doi.org\/10.3389\/fcimb.2012.00145","journal-title":"Front Cell Infect Microbiol"},{"key":"1278_CR45","doi-asserted-by":"publisher","first-page":"102108","DOI":"10.1016\/j.tube.2021.102108","volume":"129","author":"C Zhu","year":"2021","unstructured":"Zhu C, Cai Y, Mo S et al (2021) NF\u03baB\u2013mediated TET2\u2013dependent TNF promoter demethylation drives Mtb\u2013upregulation TNF expression in macrophages. Tuberculosis 129:102108. https:\/\/doi.org\/10.1016\/j.tube.2021.102108","journal-title":"Tuberculosis"},{"key":"1278_CR46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00430-017-0495-0","volume":"206","author":"JL Cervantes","year":"2017","unstructured":"Cervantes JL (2017) MyD88 in Mycobacterium tuberculosis infection. Med Microbiol Immunol 206:187\u2013193. https:\/\/doi.org\/10.1007\/s00430-017-0495-0","journal-title":"Med Microbiol Immunol"},{"key":"1278_CR47","doi-asserted-by":"publisher","first-page":"11169","DOI":"10.1073\/pnas.1107941108","volume":"108","author":"A Seubert","year":"2011","unstructured":"Seubert A, Calabro S, Santini L et al (2011) Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88. Proc Natl Acad Sci USA 108:11169\u201311174. https:\/\/doi.org\/10.1073\/pnas.1107941108","journal-title":"Proc Natl Acad Sci USA"},{"key":"1278_CR48","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4103\/ijmr.IJMR","volume":"89","author":"TK Boppana","year":"2021","unstructured":"Boppana TK, Mohan A, Madan K, Tiwari P, Hadda V, Guleria RMSC (2021) Candidate immunomodulators for COVID-19: heat-killed Mycobacterium w and BCG vaccine. Adv Respir Med 89:350\u2013351. https:\/\/doi.org\/10.4103\/ijmr.IJMR","journal-title":"Adv Respir Med"},{"key":"1278_CR49","doi-asserted-by":"publisher","first-page":"e1004485","DOI":"10.1371\/journal.ppat.1004485","volume":"10","author":"K Buffen","year":"2014","unstructured":"Buffen K, Oosting M, Quintin J et al (2014) Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer. PLoS Pathog 10:e1004485. https:\/\/doi.org\/10.1371\/journal.ppat.1004485","journal-title":"PLoS Pathog"},{"key":"1278_CR50","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1111\/j.1365-2567.2008.02962.x","volume":"128","author":"A Jeevan","year":"2009","unstructured":"Jeevan A, Bonilla DL, McMurray DN (2009) Expression of interferon-\u03b2 and tumour necrosis factor-\u03b1 messenger RNA does not correlate with protection in guinea pigs challenged with virulent Mycobacterium tuberculosis by the respiratory route. Immunology 128:e296\u2013e305. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.02962.x","journal-title":"Immunology"},{"key":"1278_CR51","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1620\/tjem.211.259","volume":"211","author":"I Sugawara","year":"2007","unstructured":"Sugawara I, Yamada H, Mizuno S (2007) BCG vaccination enhances resistance to M. tuberculosis infection in guinea pigs fed a low casein diet. Tohoku J Exp Med 211:259\u2013268. https:\/\/doi.org\/10.1620\/tjem.211.259","journal-title":"Tohoku J Exp Med"},{"key":"1278_CR52","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1086\/513642","volume":"24","author":"EA Talbot","year":"1997","unstructured":"Talbot EA, Perkins MD, Suva SFM, Frothingham R (1997) Disseminated bacille Calmette\u2013Guerin disease after vaccination: case report and review. Clin Infect Dis 24:1139\u20131146. https:\/\/doi.org\/10.1086\/513642","journal-title":"Clin Infect Dis"},{"key":"1278_CR53","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.it.2021.12.006","volume":"43","author":"JA Soto","year":"2022","unstructured":"Soto JA, G\u00e1lvez NMS, Andrade CA et al (2022) BCG vaccination induces cross-protective immunity against pathogenic microorganisms. Trends Immunol 43:322\u2013335. https:\/\/doi.org\/10.1016\/j.it.2021.12.006","journal-title":"Trends Immunol"},{"key":"1278_CR54","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S0140-6736(02)11141-X","volume":"360","author":"A Mwinga","year":"2002","unstructured":"Mwinga A, Nunn A, Ngwira B et al (2002) Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial. Lancet 360:1050\u20131055. https:\/\/doi.org\/10.1016\/S0140-6736(02)11141-X","journal-title":"Lancet"},{"key":"1278_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-03514-1","volume":"7","author":"SK Sharma","year":"2017","unstructured":"Sharma SK, Katoch K, Sarin R et al (2017) Efficacy and safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial. Sci Rep 7:1\u201312. https:\/\/doi.org\/10.1038\/s41598-017-03514-1","journal-title":"Sci Rep"},{"key":"1278_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-27029-6","volume":"12","author":"S Jenum","year":"2021","unstructured":"Jenum S, Tonby K, Rueegg CS et al (2021) A phase I\/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients. Nat Commun 12:1\u201313. https:\/\/doi.org\/10.1038\/s41467-021-27029-6","journal-title":"Nat Commun"},{"key":"1278_CR57","doi-asserted-by":"publisher","first-page":"e854","DOI":"10.1002\/iid3.854","volume":"11","author":"N Wang","year":"2023","unstructured":"Wang N, Liang Y, Ma Q et al (2023) Mechanisms of ag85a\/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis-induced injury. Immunity, Inflamm Dis 11:e854. https:\/\/doi.org\/10.1002\/iid3.854","journal-title":"Immunity, Inflamm Dis"},{"key":"1278_CR58","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nrd3426","volume":"10","author":"A Flemming","year":"2011","unstructured":"Flemming A (2011) Vaccines: nano-adjuvant: double TLR stimulation is the key. Nat Rev Drug Discov 10:258\u2013259. https:\/\/doi.org\/10.1038\/nrd3426","journal-title":"Nat Rev Drug Discov"}],"container-title":["Indian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12088-024-01278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12088-024-01278-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12088-024-01278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T16:11:44Z","timestamp":1734106304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12088-024-01278-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1007\/s12088-024-01278-7","relation":{},"ISSN":["0046-8991","0973-7715"],"issn-type":[{"value":"0046-8991","type":"print"},{"value":"0973-7715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]},"assertion":[{"value":"21 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the animal experiments were approved by the Laboratory Animal Welfare & Ethics Committee of National Institutes for Food and Drug Control (NIFDC) and the approval code is 201505.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}